SCHEMBL8682285

SCHEMBL8682285

CCOC(CCc1nn(Cc2ccccc2)c2cc(C(=O)OC)ccc12)OCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC22A12 Q96S37 4/20 0.44
▸ F2RL3 Q96RI0 1/20 0.43
▸ SLC16A3 O15427 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ APOBEC3A P31941 1/20 0.41
▸ APOBEC3G Q9HC16 1/20 0.41
▸ GAA P10253 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ S1PR3 Q99500 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.39
▸ MAPK10 P53779 1/20 0.39
▸ HDAC3 O15379 1/20 0.39
▸ HDAC1 Q13547 1/20 0.39
▸ HDAC2 Q92769 1/20 0.39
▸ HDAC10 Q969S8 1/20 0.39
▸ HDAC8 Q9BY41 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ NCOR2 Q9Y618 1/20 0.39
▸ HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7658111 0.83 KDM4E (0.37) MEN1KMT2AAPOBEC3AAPOBEC3GGAA
SCHEMBL8687237 0.82 SLC22A12 (0.44) SLC22A12F2RL3SLC16A3MEN1KMT2A
SCHEMBL1553851 0.78 SLC22A12 (0.58) SLC22A12F2RL3MEN1KMT2AAPOBEC3A
SCHEMBL8683774 0.76 SLC16A3 (0.41) SLC22A12F2RL3SLC16A3MEN1KMT2A
SCHEMBL14977876 0.73 F2RL3 (0.48) F2RL3SLC16A3MEN1KMT2AGAA
SCHEMBL8682731 0.72 KDM4E (0.39) MEN1KMT2AAPOBEC3AAPOBEC3GGAA
SCHEMBL16127813 0.71 GAA (0.52) SLC22A12F2RL3MEN1KMT2AAPOBEC3A
SCHEMBL7414619 0.70 SLC22A12 (0.46) SLC22A12MEN1KMT2AAPOBEC3AAPOBEC3G
SCHEMBL17608582 0.69 F2RL3 (0.45) F2RL3SLC16A3MEN1KMT2AGAA
SCHEMBL1553752 0.69 GAA (0.52) F2RL3MEN1KMT2AGAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5760028-A TREATING CANCER METASTASIS, DIABETIC RETINOPATHY, NEOVASCULAR GLAUCOMA, THROMBOSIS, RESTENOSIS, OSTEOPOROSIS, MACULAR DEGENERATION THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-06-02 — — US disclosed
Send feedback